annb0t
Top 20
SYDNEY, March 21, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), a late stage, oncology-focused drug development company, is pleased to announce upcoming presentations at two international conferences. Kazia Therapeutics Limited Logo (PRNewsfoto/Kazia Therapeutics Limited)
American Association of Cancer Research Annual Scientific Meeting
Four abstracts relating to Kazia's pipeline have been accepted for presentation at the upcoming American Association of Cancer Rese...
>>> Read more: KAZIA TO PRESENT AT UPCOMING INVESTOR CONFERENCE AND AACR ANNUAL SCIENTIFIC MEETING
American Association of Cancer Research Annual Scientific Meeting
Four abstracts relating to Kazia's pipeline have been accepted for presentation at the upcoming American Association of Cancer Rese...
>>> Read more: KAZIA TO PRESENT AT UPCOMING INVESTOR CONFERENCE AND AACR ANNUAL SCIENTIFIC MEETING
